0.77

0.65% -0.005

Karyopharm Therapeutics Inc (KPTI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.775

Offen:

$0.76

24-Stunden-Volumen:

228.58K

Relative Volume:

0.31

Marktkapitalisierung:

$97.09M

Einnahmen:

$140.46M

Nettoeinkommen (Verlust:

$-146.34M

KGV:

-0.5833

EPS:

-1.32

Netto-Cashflow:

$-117.73M

1W Leistung:

-8.04%

1M Leistung:

-9.88%

6M Leistung:

-31.25%

1J Leistung:

+4.31%

1-Tages-Spanne:

$0.76

$0.798

1-Wochen-Bereich:

$0.7518

$0.8886

52-Wochen-Spanne:

$0.6174

$1.95

Karyopharm Therapeutics Inc Stock (KPTI) Company Profile

Firmenname

Karyopharm Therapeutics Inc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

617-658-0600

Adresse

85 WELLS AVENUE, NEWTON, MA

Mitarbeiter

325

Twitter

@Karyopharm

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

KPTI's Discussions on Twitter

Vergleichen Sie KPTI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KPTI	0.77	97.09M	140.46M	-146.34M	-117.73M	-1.32
VRTX	449.64	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	748.66	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	589.18	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.13	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.50	24.89B	3.30B	-501.07M	1.03B	11.54

Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-01-19	Eingeleitet	Piper Sandler	Overweight
2022-11-04	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2022-02-09	Hochstufung	JP Morgan	Underweight → Neutral
2021-11-19	Fortgesetzt	Morgan Stanley	Equal-Weight
2021-08-06	Herabstufung	JP Morgan	Overweight → Neutral
2021-08-06	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2021-08-06	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-07-02	Eingeleitet	Morgan Stanley	Overweight
2020-03-04	Eingeleitet	Barclays	Overweight
2020-01-17	Herabstufung	Wedbush	Outperform → Neutral
2019-07-23	Hochstufung	JP Morgan	Neutral → Overweight
2019-07-05	Bestätigt	H.C. Wainwright	Buy
2019-07-05	Bestätigt	Robert W. Baird	Outperform
2019-03-01	Herabstufung	JP Morgan	Overweight → Neutral
2019-02-28	Bestätigt	BofA/Merrill	Underperform
2019-02-27	Herabstufung	BofA/Merrill	Neutral → Underperform
2019-01-03	Hochstufung	BofA/Merrill	Underperform → Neutral
2018-12-03	Eingeleitet	B. Riley FBR	Buy
2018-11-09	Hochstufung	Wedbush	Neutral → Outperform
2018-05-24	Herabstufung	Wedbush	Outperform → Neutral
2018-04-02	Fortgesetzt	Leerink Partners	Outperform
2017-11-15	Fortgesetzt	H.C. Wainwright	Buy
2017-09-15	Eingeleitet	RBC Capital Mkts	Outperform
2016-09-08	Bestätigt	H.C. Wainwright	Buy
2016-08-30	Hochstufung	Jefferies	Hold → Buy
2016-08-18	Eingeleitet	H.C. Wainwright	Buy
2016-06-28	Eingeleitet	Robert W. Baird	Outperform

Alle ansehen

Karyopharm Therapeutics Inc Aktie (KPTI) Neueste Nachrichten

03:42 AM

Karyopharm appoints new chief accounting officer By Investing.com - Investing.com UK

Nov 20, 2024

Karyopharm Therapeutics Inc. Appoints Kristin Abate as Chief Accounting Officer - Marketscreener.com

Nov 20, 2024

Nov 18, 2024

Karyopharm to Present New Selinexor Clinical Data at ASH 2024 Annual Meeting | KPTI Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Avidity Partners Management LP's Strategic Acquisition of Karyop - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress By Investing.com - Investing.com Nigeria

Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress - Investing.com India

Nov 14, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Rating Upgraded by StockNews.com - MarketBeat

Nov 14, 2024

GSA Capital Partners LLP Purchases 792,283 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat

Nov 14, 2024

Nov 08, 2024

Leerink Partnrs Issues Optimistic Forecast for KPTI Earnings - MarketBeat

Nov 08, 2024

What is HC Wainwright's Estimate for KPTI FY2024 Earnings? - MarketBeat

Nov 08, 2024

Karyopharm Therapeutics Falls To US$0.88, But Insiders Sold At Lower Price - Simply Wall St

Nov 08, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance

Nov 08, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

Nov 08, 2024

Karyopharm Therapeutics Reports Q3 2024 Financial Results and Corporate Progress - Defense World

Nov 08, 2024

Nov 07, 2024